Calithera Biosciences Inc...
(CALA) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Cash & Equivalents | 25.45M | 59.54M | 107.15M | 60.44M | 51.06M | 48.48M | 10.60M | 6.11M | 101.97M | 33.82M | 2.21M |
Short-Term Investments | n/a | n/a | 8.01M | 96.92M | 85.09M | 115.32M | 41.18M | 63.82M | n/a | n/a | n/a |
Long-Term Investments | n/a | 270.00K | 440.00K | 440.00K | 440.00K | 22.36M | 46.00K | 2.00M | n/a | n/a | n/a |
Other Long-Term Assets | 270.00K | n/a | n/a | 280.00K | 569.00K | 668.00K | 290.00K | 327.00K | 46.00K | 116.00K | 107.00K |
Receivables | n/a | n/a | 1.54M | 482.00K | 2.00M | 1.14M | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | -1.54M | -482.00K | -2.00M | -22.36M | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.17M | 3.83M | 2.01M | 1.95M | 2.10M | 2.73M | 3.56M | 5.13M | 3.79M | 349.00K | 67.00K |
Total Current Assets | 26.62M | 61.45M | 118.70M | 159.80M | 140.25M | 167.67M | 53.56M | 72.50M | 103.86M | 34.17M | 2.27M |
Property-Plant & Equipment | 1.78M | 3.03M | 6.44M | 8.25M | 1.46M | 1.76M | 899.00K | 931.00K | 861.00K | 559.00K | 681.00K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.05M | 3.30M | 6.88M | 8.97M | 2.47M | 24.79M | 1.24M | 3.25M | 907.00K | 675.00K | 788.00K |
Total Assets | 28.68M | 64.76M | 125.59M | 168.77M | 142.72M | 192.46M | 54.80M | 75.75M | 104.77M | 34.84M | 3.06M |
Account Payables | 732.00K | 3.65M | 1.99M | 2.05M | 1.25M | 1.07M | 398.00K | 562.00K | 693.00K | 150.00K | 25.00K |
Deferred Revenue | n/a | 8.37M | 13.05M | 1.55M | 2.47M | 29.02M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.53M | 1.37M | 1.90M | 1.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 5.13M | 8.98M | 14.50M | 16.09M | 11.17M | 8.94M | 4.05M | 3.27M | 3.43M | 1.19M | 884.00K |
Total Current Liabilities | 7.39M | 14.01M | 18.40M | 19.62M | 14.88M | 39.03M | 4.45M | 3.83M | 4.12M | 1.34M | 909.00K |
Long-Term Debt | 136.00K | 1.67M | 4.82M | 6.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 758.00K | 40.70M | n/a | n/a | 1.13M | 1.09M | 437.00K | 129.00K | 283.00K | 54.31M | 10.72M |
Total Long-Term Liabilities | 894.00K | 42.37M | 4.82M | 6.72M | 1.13M | 3.12M | 437.00K | 129.00K | 283.00K | 54.31M | 10.72M |
Total Liabilities | 8.28M | 56.37M | 23.22M | 26.34M | 16.01M | 42.15M | 4.89M | 3.96M | 4.40M | 55.66M | 11.63M |
Total Debt | 1.67M | 3.04M | 6.72M | 8.20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | n/a | 8.00K | 7.00K | 6.00K | 4.00K | 4.00K | 2.00K | 2.00K | 2.00K | 1K | n/a |
Retained Earnings | -512.62M | -491.33M | -376.24M | -286.10M | -196.17M | -150.33M | -122.50M | -84.50M | -51.85M | -30.14M | -17.77M |
Comprehensive Income | n/a | -40.70M | 3.00K | 42.00K | -113.00K | -270.00K | -13.00K | -69.00K | -1.23M | -871.00K | -610.00K |
Shareholders Equity | 20.39M | -491.33M | -376.24M | -286.10M | -196.17M | 150.31M | 49.91M | 71.79M | -51.85M | -20.81M | -8.57M |
Total Investments | 270.00K | 270.00K | 8.01M | 96.92M | 85.09M | 137.68M | 41.18M | 65.82M | n/a | n/a | n/a |